Chemotherapy News and Research

Latest Chemotherapy News and Research

Study reports longer survival for obese men with metastatic melanoma

Obese patients with metastatic melanoma who are treated with targeted or immune therapies live significantly longer than those with a normal body mass index, investigators report in a study published in Lancet Oncology of 1,918 patients in six independent clinical cohorts.

13 Feb 2018

Trump’s budget proposal swings at drug prices with a glancing blow

President Donald Trump's new budget proposal flirts with combating high prescription drug prices, but industry watchers say the tweaks to Medicare and Medicaid do little more than dance around the edges of lowering the actual prices of drugs.

13 Feb 2018

Scientists develop new array to identify biomarkers for wide range of diseases

Scientists have developed a way to identify biomarkers for a wide range of diseases by assessing the antibodies we are making to the complex sugars coating our cells.

12 Feb 2018

New imaging system helps predict chemotherapy responses in breast cancer

A new optical imaging system which uses infrared light has shown promise in predicting early responses to chemotherapy in breast cancer patients.

12 Feb 2018

Researchers refine two innovative surgery techniques for effective treatment of lymphedema

Lymphoedema is fluid retention in the tissue caused by damage to the lymphatic system and is one of the most serious side-effects of cancer operations.

12 Feb 2018

Lesser-known CRS-HIPEC treatment for cancers that have spread to abdominal cavity

While cancer treatment advances are being made in the areas of precision medicine and immunotherapy, a unique combination of traditional therapies can also provide some cancer patients a treatment option that may provide significant benefit.

11 Feb 2018

Study of men with inherited DNA repair mutations opens new therapeutic avenues in prostate cancer

Selected by the American Society of Clinical Oncology to first outing during its Genitourinary Cancers Symposium, Translating Evidence to Multidisciplinary Care, February 8 - 10 (San Francisco, USA), Joaquin Mateo, Principal Investigator of VHIO's recently created Prostate Cancer Translational Research Group, will today reveal findings from a retrospective and international study showing for the first time that patients with inherited DNA repair mutations benefit from standard therapies in a similar way to other metastatic prostate cancer patients.

9 Feb 2018

Lab-grown eggs could combat infertility

Researchers have successfully developed human eggs in a laboratory in a major scientific first.

9 Feb 2018

Scientists develop new technique to 'turn off' multi-drug resistance capabilities in cancer cells

The ability for cancer cells to develop resistance to chemotherapy drugs - known as multi-drug resistance - remains a leading cause for tumor recurrence and cancer metastasis, but recent findings offer hope that oncologists could one day direct cancer cells to "turn off" their resistance capabilities.

8 Feb 2018

HDAC6 inhibition could be promising therapeutic approach for peripheral neuropathies

Inhibiting HDAC6 improves the structural stability of cells and protects against neuronal damage. Leuven research uncovered that targeting this mechanism could be a promising therapeutic approach for peripheral neuropathies, whether due to Charcot-Marie-Tooth disease (CMT) or as a side effect of chemotherapy.

8 Feb 2018

Scientists find way to reduce breast cancer spread

Scientists have discovered that an amino acid called asparagine is essential for breast cancer spread, and by restricting it, cancer cells stopped invading other parts of the body in mice, according to research part-funded by Cancer Research UK and published in the journal Nature today, (Wednesday).

7 Feb 2018

Health indicators for children born to breast cancer survivors may depend on cancer type

For breast cancer survivors, the risk of giving birth prematurely, and for other health concerns for their newborns, may depend on the type of breast cancer they had, according to a study from University of North Carolina Lineberger Comprehensive Cancer Center researchers.

6 Feb 2018

Scientists target tumor suppressor as a new treatment approach to 'triple-negative' breast cancer

Researchers studying “triple-negative” breast cancer have found that the loss of a specific tumor suppressor provides clues about potential new treatments.

6 Feb 2018

Researchers devise strategies to target glioma stem cells that could improve patient survival

Glioblastoma multiforme is the most common and aggressive primary brain tumor and has one of the worst survival rates of all cancers.

5 Feb 2018

Study uncovers potential targets for treatment of aggressive triple-negative breast cancers

As part of a breast-cancer diagnosis, doctors analyze the tumor to determine which therapies might best attack the malignancy.

2 Feb 2018

Breast cancer treatments increase the risk of heart disease, warns the AHA

The American Heart Association highlights the need to monitor cardiovascular health in women receiving treatment for breast cancer.

2 Feb 2018

NCCN joins call for urgent action to reduce rate of premature cancer deaths

On Sunday February 4, the National Comprehensive Cancer Network (NCCN) will stand with cancer leaders, health professionals, and supporters across the world to acknowledge World Cancer Day.

2 Feb 2018

Paxman introduces new Clinical Pioneer initiative to mark World Cancer Day

British scalp cooling pioneer Paxman, has launched the first ever ‘Clinical Pioneer Program’ to mark World Cancer Day.

2 Feb 2018

New scientific statement reveals shared risk factors and cardiotoxic effects of cancer therapy

A new scientific statement issued today by the American Heart Association underscores the commonalities between cardiovascular disease and breast cancer among women, and it calls for more focus on research and specialized treatment where the diseases overlap.

1 Feb 2018

Historic study involving Simmons Cancer Center shows effectiveness of CAR-T therapy

A historic study involving researchers from UT Southwestern's Harold C. Simmons Comprehensive Cancer Center demonstrates the effectiveness of CAR-T therapy, which uses genetically modified immune cells to treat acute lymphoblastic leukemia (ALL) in children and young adults. The research appears in the New England Journal of Medicine.

1 Feb 2018

Chemotherapy News and Research

Latest Chemotherapy News and Research

Study reports longer survival for obese men with metastatic melanoma

Trump’s budget proposal swings at drug prices with a glancing blow

Scientists develop new array to identify biomarkers for wide range of diseases

New imaging system helps predict chemotherapy responses in breast cancer

Researchers refine two innovative surgery techniques for effective treatment of lymphedema

Lesser-known CRS-HIPEC treatment for cancers that have spread to abdominal cavity

Study of men with inherited DNA repair mutations opens new therapeutic avenues in prostate cancer

Lab-grown eggs could combat infertility

Scientists develop new technique to 'turn off' multi-drug resistance capabilities in cancer cells

HDAC6 inhibition could be promising therapeutic approach for peripheral neuropathies

Scientists find way to reduce breast cancer spread

Health indicators for children born to breast cancer survivors may depend on cancer type

Scientists target tumor suppressor as a new treatment approach to 'triple-negative' breast cancer

Researchers devise strategies to target glioma stem cells that could improve patient survival

Study uncovers potential targets for treatment of aggressive triple-negative breast cancers

Breast cancer treatments increase the risk of heart disease, warns the AHA

NCCN joins call for urgent action to reduce rate of premature cancer deaths

Paxman introduces new Clinical Pioneer initiative to mark World Cancer Day

New scientific statement reveals shared risk factors and cardiotoxic effects of cancer therapy

Historic study involving Simmons Cancer Center shows effectiveness of CAR-T therapy

Cancer Research - Second Edition eBook

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Chemotherapy News and Research

Latest Chemotherapy News and Research

Cancer Research - Second Edition eBook

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Newsletters you may be interested in